Archives
- o2h Ventures invests in ClotProtect, a Company Developing Treatment to Improve Bleeding and Survival Outcomes 22 April, 2024
- o2h Ventures Invests in Stratosvir – Advancing Viral Immunotherapy For Late-Stage Cancer 17 April, 2024
- o2h Ventures Announces SEIS Investment in Innovative mRNA-Based Hearing Loss Treatment Company, CamGene Therapeutics 05 April, 2024
- Pioneering innovation in biotech investments via o2h Ventures’ human health S/EIS funds 20 February, 2024
- Fuelling academic innovation and fostering entrepreneurship 08 January, 2024
- o2h Ventures – Embracing autumn with exciting updates and amazing achievements! 12 October, 2023
- o2h Ventures continues to back Pencil Biosciences in its £5.6M Seed investment 29 September, 2023
- o2h Ventures qualified as a finalist as Best EIS Manager – Specialist at Growth Investor Awards 2023 14 August, 2023
- o2h Ventures selected as finalist for best seed VC in UKBAA awards 2023 14 June, 2023
invest in the growth potential of UK life science & AI